NEW YORK (Reuters Health) – Patients with metastatic melanoma that has relapsed following anti-PD-1 therapies or BRAF/MEK inhibitors may not
Read moreHome ยป
melanoma
Melanoma of the eye: Preclinical tests show path toward treatment
Uveal melanoma, or UM, is a rare and deadly cancer of the eye, and the mortality rate has remained unimproved
Read moreCancer Diagnoses Delayed Among Prisoners in Washington State
The lesion started out small, maybe the size of a Q-tip, but then rapidly progressed to the size of a
Read moreTebentafusp improves OS: A First in Metastatic Uveal Melanoma
First-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in
Read moreCommon Blood Pressure Medications Linked to Increased Skin Cancer Risk
(Reuters Health) – Thiazide diuretics, which are used by many older patients to control blood pressure, are linked to increased
Read moreyasmin kister
In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can
Read moreForty-three percent of melanoma patients have chronic complications from immunotherapies
Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a
Read moreGene-based blood test for melanoma spread evaluates treatment progress
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early
Read moreScientists avert drug resistance in subtype of brain tumors
In far too many cases over the years, Scientists avert drug resistance in subtype of brain tumorshave discovered promising new
Read moreWhat is eye cancer?
Eye cancer, as the name suggests begins in the eye. The eye is composed of various smaller structures each of
Read more